Time resolved characterization of the development of NAFLD and the role of the gut and white adipose tissue therein.

Medicine & Life Sciences

1. Non-alcoholic Fatty Liver Disease 100%
2. Obesity 32%
3. White Adipose Tissue 21%
4. Adipose Tissue 19%
5. Publications 19%
6. Atherosclerosis 18%
7. Fatty Liver 18%
8. Food 16%
9. Mentors 14%
10. Technology 11%
11. Health 11%
12. proxigermanium 10%
13. 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid 10%
14. Inflammation 10%
15. Organizations 9%
16. Insulin Resistance 9%
17. casein hydrolysate 9%
18. Disease Progression 9%
19. interleukin-1beta-converting enzyme inhibitor 9%
20. Public-Private Sector Partnerships 8%
21. Nutrigenomics 8%
22. Nutrition Therapy 8%
23. Passive Cutaneous Anaphylaxis 7%
24. Rosiglitazone 7%
25. Biomedical Technology 7%
26. Volatile Fatty Acids 7%
27. Obese Mice 7%
28. Atorvastatin 7%
29. Phenotype 6%
30. Nutritionists 6%
31. Drug Industry 6%
32. Therapeutics 6%
33. Gastroenterology 6%
34. Metabolomics 6%
35. Hyperinsulinism 6%
36. Precision Medicine 6%
37. Literature 6%
38. Metabolic Diseases 6%
39. Bile Acids and Salts 6%
40. Liver 5%
41. High Fat Diet 5%
42. Animals 5%
43. Microbiota 5%
44. Congresses 5%
45. Gastrointestinal Microbiome 5%
46. DNA Methylation 5%
47. Pathologists 5%
48. Dyslipidemias 5%
49. Industry 5%
50. Overweight 5%
51. Child 5%